Currently, there are 161.78M common shares owned by the public and among those 158.39M shares have been available to trade.
The company’s stock has a 5-day price change of 2.11% and 10.32% over the past three months. ALKS shares are trading 11.13% year to date (YTD), with the 12-month market performance up to 19.39% higher. It has a 12-month low price of $22.90 and touched a high of $32.88 over the same period. ALKS has an average intraday trading volume of 1.52 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 3.52%, 5.89%, and 17.16% respectively.
Institutional ownership of Alkermes plc (NASDAQ: ALKS) shares accounts for 106.58% of the company’s 161.78M shares outstanding.
It has a market capitalization of $5.17B and a beta (3y monthly) value of 0.64. The stock’s trailing 12-month PE ratio is 16.28, while the earnings-per-share (ttm) stands at $1.96. The company has a PEG of 1.57 and a Quick Ratio of 3.03 with the debt-to-equity ratio at 0.28. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.09% over the week and 2.59% over the month.
Earnings per share for the fiscal year are expected to increase by 82.03%, and -33.29% over the next financial year.
Looking at the support for the ALKS, a number of firms have released research notes about the stock. Deutsche Bank stated their Buy rating for the stock in a research note on February 11, 2025, with the firm’s price target at $40. Stifel coverage for the Alkermes plc (ALKS) stock in a research note released on November 05, 2024 offered a Buy rating with a price target of $36. TD Cowen was of a view on June 17, 2024 that the stock is Buy, while Robert W. Baird gave the stock Outperform rating on March 19, 2024, issuing a price target of $37. UBS on their part issued Sell rating on February 20, 2024.
